JPWO2022114122A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022114122A5 JPWO2022114122A5 JP2022565447A JP2022565447A JPWO2022114122A5 JP WO2022114122 A5 JPWO2022114122 A5 JP WO2022114122A5 JP 2022565447 A JP2022565447 A JP 2022565447A JP 2022565447 A JP2022565447 A JP 2022565447A JP WO2022114122 A5 JPWO2022114122 A5 JP WO2022114122A5
- Authority
- JP
- Japan
- Prior art keywords
- hydroxymethyl
- tetrahydroquinoline
- fluoro
- hydroxy
- carboxamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020199206 | 2020-11-30 | ||
| PCT/JP2021/043375 WO2022114122A1 (ja) | 2020-11-30 | 2021-11-26 | 神経障害性疼痛を緩和させるための医薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022114122A1 JPWO2022114122A1 (https=) | 2022-06-02 |
| JPWO2022114122A5 true JPWO2022114122A5 (https=) | 2023-08-16 |
Family
ID=81755628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022565447A Withdrawn JPWO2022114122A1 (https=) | 2020-11-30 | 2021-11-26 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240009180A1 (https=) |
| EP (1) | EP4272758A4 (https=) |
| JP (1) | JPWO2022114122A1 (https=) |
| KR (1) | KR20230096055A (https=) |
| CN (1) | CN116782901A (https=) |
| AU (1) | AU2021389409A1 (https=) |
| CA (1) | CA3198258A1 (https=) |
| IL (1) | IL302972A (https=) |
| MX (1) | MX2023006289A (https=) |
| TW (1) | TW202237111A (https=) |
| WO (1) | WO2022114122A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121159455A (zh) * | 2024-06-18 | 2025-12-19 | 武汉人福创新药物研发中心有限公司 | 氨基酯类化合物及其作为p2x7拮抗剂的用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013269606B2 (en) | 2012-06-01 | 2018-05-17 | Ablynx N.V. | P2X7 receptor antagonists and agonists |
| JP6301920B2 (ja) | 2013-05-27 | 2018-03-28 | 国立大学法人 岡山大学 | 疼痛治療薬 |
| US11077100B2 (en) * | 2017-03-13 | 2021-08-03 | Raqualia Pharma Inc. | Tetrahydroquinoline derivatives as P2X7 receptor antagonists |
| EP3398941A1 (en) | 2017-05-03 | 2018-11-07 | AXXAM S.p.A. | Heterocyclic p2x7 antagonists |
| JP7311944B2 (ja) | 2018-04-16 | 2023-07-20 | 塩野義製薬株式会社 | 二環性含窒素複素環誘導体を含有する医薬組成物 |
| JP2019182806A (ja) | 2018-04-16 | 2019-10-24 | 塩野義製薬株式会社 | 二環性複素環誘導体およびそれらを含有する医薬組成物 |
-
2021
- 2021-11-26 JP JP2022565447A patent/JPWO2022114122A1/ja not_active Withdrawn
- 2021-11-26 US US18/254,270 patent/US20240009180A1/en active Pending
- 2021-11-26 EP EP21898094.4A patent/EP4272758A4/en not_active Withdrawn
- 2021-11-26 IL IL302972A patent/IL302972A/en unknown
- 2021-11-26 AU AU2021389409A patent/AU2021389409A1/en not_active Abandoned
- 2021-11-26 TW TW110144115A patent/TW202237111A/zh unknown
- 2021-11-26 KR KR1020237017766A patent/KR20230096055A/ko not_active Withdrawn
- 2021-11-26 CA CA3198258A patent/CA3198258A1/en active Pending
- 2021-11-26 CN CN202180080359.2A patent/CN116782901A/zh active Pending
- 2021-11-26 WO PCT/JP2021/043375 patent/WO2022114122A1/ja not_active Ceased
- 2021-11-26 MX MX2023006289A patent/MX2023006289A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023002846A5 (https=) | ||
| US20080152709A1 (en) | Clonidine composition and method of use | |
| US8536138B2 (en) | Treatment of pulmonary hypertension with carbonic anhydrase inhibitors | |
| JP2020508339A5 (https=) | ||
| JP5866116B2 (ja) | 嘔吐および下痢などの状態を解消または軽減するためのコーティングされた薬物球状体およびその用途 | |
| US11666582B2 (en) | Medicament for treating cough | |
| CN1929845A (zh) | Pdeⅲ抑制剂用于降低患有心力衰竭的哺乳动物的心脏大小的用途 | |
| JP2010514696A (ja) | 心血管症状の低減 | |
| US20260027139A1 (en) | Treatment of sleep apnea with a combination of a carbonic anhydrase inhibitor and an aldosterone antagonist | |
| BG102669A (bg) | Метод за лечение и фармацевтичен състав | |
| US20020016342A1 (en) | Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor | |
| CN107205950A (zh) | 金刚烷胺组合物的施用方法 | |
| JPWO2022114122A5 (https=) | ||
| JP2001520174A (ja) | 心血管疾患および脳血管疾患に関するリスクを低下させる併用療法 | |
| US20090175938A1 (en) | Controlled Release Flurbiprofen and Muscle Relaxant Combinations | |
| EP2152232A1 (en) | Methods and compositions for administration of oxybutynin | |
| JP7474760B2 (ja) | Ｔａｓｋ－１およびｔａｓｋ－３チャンネル阻害剤を含有する医薬投薬形態の製造方法、ならびに呼吸障害治療におけるその使用 | |
| JPWO2017184774A5 (https=) | ||
| EP4615585A1 (en) | Methods of using trazodone to reverse the effects of 5-ht2a receptor agonists | |
| JP2024523876A (ja) | 睡眠時無呼吸を治療するためのノルエピネフリン再取り込み阻害剤 | |
| JP2007509900A5 (https=) | ||
| CN1893946A (zh) | 吡唑衍生物在制备用于预防和治疗异常脂血症以及与异常脂血症和/或肥胖有关的疾病的药物中的应用 | |
| JPWO2021245280A5 (https=) | ||
| CN1960631A (zh) | 苯甲酰胺和苯甲酸酯抗hiv化合物 | |
| HK40048225A (en) | Process for producing pharmaceutical dosage forms containing task-1 and task-3 channel inhibitors and the use of same in breathing disorder therapy |